AT1R-Selective Negative Allosteric Modulator Targeting the Epitope for Pathogenic Autoantibody Activation
A major therapeutic strategy for managing cardiovascular and renal diseases is the use of angiotensin receptor blockers (ARBs). These drugs block both path